Petra Baumgaertner

机构：University of Lausanne · ORCID：0000-0002-5979-7654

发表论文 141 篇 · 总被引 6498 次 · h-index 31

代表论文

Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors (2023 · Nature Communications · 被引 68)
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs (2023 · Cell Reports Methods · 被引 49)
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma (2023 · Cancer Research · 被引 20)
Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors (2025 · Preprints.org · 被引 2)
Pre-operative intratumoral toll-like receptor 9 (TLR9) agonist vidutolimod (Vidu) and stereotactic body radiation therapy (SBRT) in early triple-negative breast cancer (eTNBC): Randomized phase 2 CyberImmunoBreast trial. (2026 · Journal of Clinical Oncology)
Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors (2025 · Biomedicines)